Corrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083]
Int Immunopharmacol. 2024 Jun 15:134:112270.
doi: 10.1016/j.intimp.2024.112270.
Epub 2024 May 18.
1 School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China; Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
2 School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
3 Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
4 Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
5 National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: wanghy@ivdc.chinacdc.cn.
6 Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China; Institute of Medical Sciences, General Hospital of Ningxia Medical University, Diagnosis and Treatment Engineering Technology Research Center of Nervous System Diseases of Ningxia Hui Autonomous Region, Yinchuan, China. Electronic address: wangzhenhai1968@163.com.